Mélanie Uguen

8PUBLICATIONS
38CO-AUTHORS
Cheminformatics and quantitative structure-activity relationshipsGene and molecular therapyMicro-manipulationHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|May 20, 2026
Introducing the 2026 Early Career Board of ACS Medicinal Chemistry Letters.

|Feb 24, 2025
Potent and selective SETDB1 covalent negative allosteric modulator reduces methyltransferase activity in cells.

Mélanie Uguen, Devan J Shell, Madhushika Silva

|Dec 24, 2024
Tudor-Containing Methyl-Lysine and Methyl-Arginine Reader Proteins: Disease Implications and Chemical Tool Development.

Mélanie Uguen, Tongkun Liu, Lindsey I James

|Oct 10, 2024
Potent and Selective SETDB1 Covalent Negative Allosteric Modulator Reduces Methyltransferase Activity in Cells.

Mélanie Uguen, Devan J Shell, Madhushika Silva

|Aug 09, 2023
SETDB1 Triple Tudor Domain Ligand, (R,R)-59, Promotes Methylation of Akt1 in Cells.

Mélanie Uguen, Yu Deng, Fengling Li

|May 22, 2023
SETDB1 Triple Tudor Domain Ligand, ( R,R )-59, Promotes Methylation of Akt1 in Cells.

Mélanie Uguen, Yu Deng, Fengling Li

Pageof 2

Frequent Collaborators

5 joint publications

Stephen V Frye

4 joint publications

Kenneth H Pearce

4 joint publications

Suzanne Ackloo

4 joint publications

Lindsey I James